( The safety profile of liraglutide in our cohort was consistent with previous pediatric randomized controlled trials (RCTs), with adverse events (AEs) predominantly mild and gastrointestinal in nature, including nausea, vomiting, and diarrhea, reported in 43.6% of participants ( Despite these favorable outcomes, the discontinuation rate during the dose-escalation phase was relatively high (25.6%), mirroring patterns observed in other pediatric liraglutide trials where treatment withdrawal often occurred during the initial weeks, coinciding with peak gastrointestinal symptoms ( A key strength of this study lies in its conduct within a publicly funded healthcare system, entirely independent of pharmaceutical industry sponsorship, thereby enhancing both methodological rigor and external validity
Voluntary fortification of food products with folic acid takes place in a lot of countries (in some of them also along with the mandatory one), e.g., Canada, the U.S.A., the Dominican Republic, Sierra Leone, Sudan, Eswatini, Saudi Arabia, Kuwait, Iraq, India, Bangladesh, Myanmar, China, and many European countries 458,587,612,614,642,654,660,688,694,695,696,697,698,699,700,701,702,703,704,705,706,707,708,709
LG 'LB54640' ,
Some approaches include: BCL-2/BCL-xL inhibitors (e.g., navitoclax), tyrosine kinase inhibitors, metabolic stressors, or even immune-based clearance
